221 Participants Needed

Community Investment for Child Health and Well-being

HA
AV
Overseen ByAditi Vasan
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Assigned Interventions in the Community Investment for Child Health and Well-being trial?

The research highlights the importance of structured child- and parent-reported outcome measures in identifying children at risk and improving health outcomes. Additionally, cross-sector partnerships and community-connected opportunities are emphasized as effective strategies for advancing child health equity, which may support the effectiveness of the treatment in the trial.12345

Is the treatment generally safe for humans?

The research articles provided do not contain specific safety data for the treatment in question, as they focus on adverse events related to cosmetics, emergency department treatments, and injury prevention strategies, rather than the treatment itself.678910

How does the 'Community Investment for Child Health and Well-being' treatment differ from other treatments for child health?

This treatment is unique because it combines community gardens, nutrition workshops, and parenting workshops to improve child health and development, focusing on reducing food insecurity and language delays. Unlike traditional medical treatments, it involves community health promoters and a 'step-by-step' learning system to empower caregivers with skills in gardening, nutrition, and parenting.1112131415

What is the purpose of this trial?

Black children and adults in the United States fare worse across nearly every health indicator compared to White individuals. In Philadelphia, the location of this study, these health disparities result in a stark longevity gap, with average life expectancies in poor, predominantly Black neighborhoods being 20 years lower than in nearby affluent, predominantly White neighborhoods. The investigators will conduct a cluster randomized controlled trial (RCT) of a suite of place- based and financial-wellbeing interventions at the community, organization, and individual/household levels that address the social determinants of racial health disparities. At the community level, the investigators address underinvestment in Black neighborhoods by implementing vacant lot greening, abandoned house remediation, tree planting, and trash cleanup. At the organization level, the investigators partner with community-based financial empowerment providers to develop cross-organizational infrastructure to increase reach and maximize efficiency. At the individual/household levels, the investigators increase access to public benefits, financial counseling and tax preparation services, and emergency cash assistance. The investigators will test this "big push" intervention in 60 Black neighborhood micro-clusters, with a total of 480 children. The investigators hypothesize that this "big push" intervention will have significant impact on children's health and wellbeing.

Research Team

AV

Aditi Vasan, MD, MSHP

Principal Investigator

Children's Hospital of Philadelphia

AV

Atheendar Venkataramani, MD, PhD

Principal Investigator

University of Pennsylvania

ES

Eugenia South, MD, MSHP

Principal Investigator

University of Pennsylvania

Eligibility Criteria

This trial is for Black children aged 3-17 and their caregivers who are knowledgeable about household finances, can text message, and communicate in English. The child must be a permanent resident of the home within the study area. Families planning to move soon or unable to consent fully are excluded.

Inclusion Criteria

I am comfortable communicating in English.
Parent/caregiver has the ability to communicate via text messaging
Parent/caregiver has knowledge of their household finances
See 2 more

Exclusion Criteria

Children who plan to move out of the study microcluster within 6 months
My caregiver cannot fully consent or participate in the trial as assessed by the clinical team.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants in the intervention arm receive place-based and financial well-being interventions, including tax preparation, access to public benefits, financial counseling, microgrants, abandoned house remediation, trash cleanup, vacant lot greening, and tree planting.

24 months

Follow-up

Participants are monitored for safety and effectiveness after the intervention, focusing on various health and well-being measures.

24 months

Treatment Details

Interventions

  • Assigned Interventions
Trial Overview The IGNITE for Kids Study tests interventions aimed at improving health and well-being by investing in Black neighborhoods. This includes greening lots, fixing houses, planting trees, cleaning trash, financial counseling, tax help, public benefits access, and emergency cash assistance.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
At the individual level, participants in the intervention arm will receive place-based and financial well-being interventions. These will include, at the individual level: * Tax preparation * Access to public benefits * Financial counseling and microgrants At the neighborhood level: * Abandoned house remediation * Trash cleanup * Vacant lot greening * Tree planting
Group II: Control ArmActive Control1 Intervention
Participants in the control arm will not receive any of the listed interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Children's Hospital of Philadelphia

Collaborator

Trials
749
Recruited
11,400,000+

Findings from Research

From 2004 to 2016, only 166 adverse events related to baby personal care products were reported to the FDA, with most cases involving skin reactions like rashes, and nearly half of these incidents required a healthcare visit.
The study highlights the need for pediatric dermatologists to actively report adverse events and encourage consumers to do the same, as current reporting is low and may not fully capture the safety concerns associated with these products.
Adverse events reported to the Food and Drug Administration from 2004 to 2016 for cosmetics and personal care products marketed to newborns and infants.Cornell, E., Kwa, M., Paller, AS., et al.[2018]
In a systematic review of 17 studies involving children, the incidence of adverse drug reactions (ADRs) in hospitalized children was found to be 9.53%, with severe reactions accounting for 12.29%, highlighting the significant risk of ADRs in this population.
The study revealed that 2.09% of pediatric hospital admissions were due to ADRs, with 39.3% of these being life-threatening, indicating a critical need for improved drug safety monitoring and preventive strategies in pediatric healthcare.
Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.Impicciatore, P., Choonara, I., Clarkson, A., et al.[2023]
In a study of 1367 children treated in a pediatric emergency department, 2.5% experienced adverse events related to their care, highlighting a significant risk of harm in this setting.
Most of these adverse events (87.9%) were deemed preventable, with management and diagnostic issues being the most common types, indicating areas where patient safety can be improved.
Adverse events in the paediatric emergency department: a prospective cohort study.Plint, AC., Stang, A., Newton, AS., et al.[2021]

References

Implementation of the norwegian 'Starting right' child health service innovation: implementation adjustments, adoption, and acceptability. [2021]
How paediatricians can improve developmental outcomes for children. [2020]
Outcomes research on children, adolescents, and their families: directions for future inquiry. [2019]
Implementation of child-centred outcome measures in routine paediatric healthcare practice: a systematic review. [2023]
Pursuing a Cross-Sector Approach to Advance Child Health Equity. [2023]
Adverse events reported to the Food and Drug Administration from 2004 to 2016 for cosmetics and personal care products marketed to newborns and infants. [2018]
Individual-level injury prevention strategies in the clinical setting. [2019]
Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. [2023]
Adverse events in the paediatric emergency department: a prospective cohort study. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Transcatheter Occlusion of the Patent Ductus Arteriosus in 747 Infants [2019]
Whole of Systems Trial of Prevention Strategies for Childhood Obesity: WHO STOPS Childhood Obesity. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Diet and behavior in at-risk children: evaluation of an early intervention program. [2019]
Research and Evaluation in a Child-Focused Place-Based Initiative: West Philly Promise Neighborhood. [2023]
A Multi-Sectoral Approach Improves Early Child Development in a Disadvantaged Community in Peru: Role of Community Gardens, Nutrition Workshops and Enhanced Caregiver-Child Interaction: Project "Wawa Illari". [2021]
Community-based intervention packages facilitated by NGOs demonstrate plausible evidence for child mortality impact. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security